Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin in preventing ARDS
NCT01314066Phase 2Withdrawn
- Sponsor
- Weill Cornell Medicine
- Start
- Jul 2010
- Primary completion
- Nov 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in acute respiratory distress syndrome (ARDS), sponsored by Weill Cornell Medicine. Planned start Jul 2010; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT01314066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01314066.